CLINICAL_TRIALS
trial_result
· 2023-01-30
Clinical Trial Update: Salvage Peanut Oral Immunotherapy Study [Phase 1, Phase 2]
Summary
Clinical trial update for salvage peanut oral immunotherapy in peanut allergy completed with results posted in 2023.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Snippet
Sponsor: University of North Carolina, Chapel Hill | Conditions: Peanut Allergy | Phase 1, Phase 2 | Status: COMPLETED | Results posted: 2023-01-30